Non-coding and Coding Transcriptional Profiles Are Significantly Altered in Pediatric Retinoblastoma Tumors.

DRAIC LNC targeting LNC-RNAs RNA-sequencing retinoblastoma

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2019
Historique:
received: 16 10 2018
accepted: 12 03 2019
entrez: 7 5 2019
pubmed: 7 5 2019
medline: 7 5 2019
Statut: epublish

Résumé

Retinoblastoma is a rare pediatric tumor of the retina, caused by the homozygous loss of the Retinoblastoma 1 (RB1) tumor suppressor gene. Previous microarray studies have identified changes in the expression profiles of coding genes; however, our understanding of how non-coding genes change in this tumor is absent. This is an important area of research, as in many adult malignancies, non-coding genes including LNC-RNAs are used as biomarkers to predict outcome and/or relapse. To establish a complete and in-depth RNA profile, of both coding and non-coding genes, in Retinoblastoma tumors, we conducted RNA-seq from a cohort of tumors and normal retina controls. This analysis identified widespread transcriptional changes in the levels of both coding and non-coding genes. Unexpectedly, we also found rare RNA fusion products resulting from genomic alterations, specific to Retinoblastoma tumor samples. We then determined whether these gene expression changes, of both coding and non-coding genes, were also found in a completely independent Retinoblastoma cohort. Using our dataset, we then profiled the potential effects of deregulated LNC-RNAs on the expression of neighboring genes, the entire genome, and on mRNAs that contain a putative area of homology. This analysis showed that most deregulated LNC-RNAs do not act locally to change the transcriptional environment, but potentially function to modulate genes at distant sites. From this analysis, we selected a strongly down-regulated LNC-RNA in Retinoblastoma, DRAIC, and found that restoring DRAIC RNA levels significantly slowed the growth of the Y79 Retinoblastoma cell line. Collectively, our work has generated the first non-coding RNA profile of Retinoblastoma tumors and has found that these tumors show widespread transcriptional deregulation.

Identifiants

pubmed: 31058073
doi: 10.3389/fonc.2019.00221
pmc: PMC6477087
doi:

Types de publication

Journal Article

Langues

eng

Pagination

221

Subventions

Organisme : NCI NIH HHS
ID : K22 CA204352
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016058
Pays : United States

Références

Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Genome Biol. 2003;4(10):R69
pubmed: 14519204
BMC Genomics. 2016 Jan 11;17 Suppl 1:12
pubmed: 26818453
Science. 1989 Feb 17;243(4893):934-7
pubmed: 2537532
Curr Protoc Bioinformatics. 2009 Sep;Chapter 13:Unit 13.11
pubmed: 19728287
Nat Genet. 1994 Sep;8(1):23-6
pubmed: 7987388
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Genes Dev. 1992 Feb;6(2):177-85
pubmed: 1531329
Mol Vis. 2010 Jul 13;16:1292-303
pubmed: 20664703
Cancer Res. 1993 Nov 15;53(22):5535-41
pubmed: 8221695
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4916-4926
pubmed: 27654418
Genomics. 2007 Sep;90(3):344-53
pubmed: 17604597
F1000Res. 2015 Oct 14;4:1070
pubmed: 26674615
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3065-73
pubmed: 19151399
Chin J Cancer Res. 2016 Feb;28(1):65-71
pubmed: 27041928
Clin Proteomics. 2016 Oct 26;13:29
pubmed: 27799869
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Nat Cell Biol. 2005 Apr;7(4):420-8
pubmed: 15750587
Nucleic Acids Res. 2017 Jan 4;45(D1):D183-D189
pubmed: 27899595
Pharm Res. 2014 Nov;31(11):3060-72
pubmed: 24906597
Nature. 1986 Oct 16-22;323(6089):643-6
pubmed: 2877398
Cell. 1999 Sep 17;98(6):859-69
pubmed: 10499802
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
Nature. 2012 Jan 11;481(7381):329-34
pubmed: 22237022
Pediatr Hematol Oncol. 2001 Apr-May;18(3):173-9
pubmed: 11293284
Br J Ophthalmol. 2009 Jan;93(1):21-3
pubmed: 18621794
Cancer Cell. 2011 Aug 16;20(2):260-75
pubmed: 21840489
Genes Dev. 2015 Sep 1;29(17):1875-89
pubmed: 26314710
Genes Dev. 2016 Jul 1;30(13):1492-502
pubmed: 27401552
Nat Protoc. 2013 Sep;8(9):1765-86
pubmed: 23975260
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5436-40
pubmed: 7777526
Science. 1994 Jul 15;265(5170):415-7
pubmed: 8023167
Br J Haematol. 1990 Oct;76(2):221-5
pubmed: 2094324
Nature. 1984 May 31-Jun 6;309(5967):458-60
pubmed: 6728001
Br J Cancer. 2013 Jul 23;109(2):512-25
pubmed: 23756868
Nature. 2006 Nov 2;444(7115):61-6
pubmed: 17080083
J Natl Cancer Inst. 1993 Jul 21;85(14):1121-8
pubmed: 8320741
F1000Res. 2015 Dec 30;4:1521
pubmed: 26925227
Methods Mol Biol. 2009;563:123-40
pubmed: 19597783
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Breast Cancer Res. 2008;10(5):R75
pubmed: 18782450
EBioMedicine. 2015 Jul 17;2(7):623-4
pubmed: 26288828
Cancer Genet Cytogenet. 1988 Jul 1;33(1):25-7
pubmed: 2838158
Mol Cancer Res. 2015 May;13(5):828-38
pubmed: 25700553
Mol Biol Cell. 1997 Feb;8(2):287-301
pubmed: 9190208

Auteurs

Swetha Rajasekaran (S)

Department of Molecular Genetics, The Ohio State University, Columbus, OH, United States.
The Ohio State University Comprehensive Cancer Center, Columbus, OH,, United States.
Center for RNA Biology, The Ohio State University, Columbus, OH, United States.

Lakshmi Dhevi Nagarajha Selvan (LD)

Department of Nanobiotechnology, Vision Research Foundation, Sankara Nethralaya, Chennai, India.

Kathleen Dotts (K)

Department of Molecular Genetics, The Ohio State University, Columbus, OH, United States.
The Ohio State University Comprehensive Cancer Center, Columbus, OH,, United States.
Center for RNA Biology, The Ohio State University, Columbus, OH, United States.

Ranjith Kumar (R)

Department of Nanobiotechnology, Vision Research Foundation, Sankara Nethralaya, Chennai, India.

Pukhraj Rishi (P)

Shri Bhagwan Mahavir Vitreoretinal Services and Ocular Oncology Services, Medical Research Foundation, Sankara Nethralaya, Chennai, India.

Vikas Khetan (V)

Shri Bhagwan Mahavir Vitreoretinal Services and Ocular Oncology Services, Medical Research Foundation, Sankara Nethralaya, Chennai, India.

Madhoolika Bisht (M)

Department of Molecular Genetics, The Ohio State University, Columbus, OH, United States.
The Ohio State University Comprehensive Cancer Center, Columbus, OH,, United States.
Center for RNA Biology, The Ohio State University, Columbus, OH, United States.

Karthikeyan Sivaraman (K)

MedGenome, Bangalore, India.

Subrmanian Krishnakumar (S)

L&T Department of Ocular Pathology, Vision Research Foundation, Chennai, India.

Debashis Sahoo (D)

Department of Pediatrics and Department of Computer Science and Engineering, University of California, San Diego, San Diego, CA, United States.

Moray J Campbell (MJ)

Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH, United States.

Sailaja V Elchuri (SV)

Department of Nanobiotechnology, Vision Research Foundation, Sankara Nethralaya, Chennai, India.

Wayne O Miles (WO)

Department of Molecular Genetics, The Ohio State University, Columbus, OH, United States.
The Ohio State University Comprehensive Cancer Center, Columbus, OH,, United States.
Center for RNA Biology, The Ohio State University, Columbus, OH, United States.

Classifications MeSH